ACUTE DISSEMINATED ENCEPHALOMYELITIS POST SARS-COV-2 VACCINATION

Many of the central and peripheral nervous system complications related to severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection have been recently described. An efficient mass vaccination program is required in order effectively reduce spreading and, therefore, minimize long-term sequelae, including neurological ones. Nonetheless, as more patients are accessing 2019 (COVID-19) vaccines, it important report potential adverse events. For this reason, we here, case a patient with no remarkable medical history, having developed disseminated encephalomyelitis (ADEM) 3 weeks after being vaccinated against COVID-19 Diagnostic criteria for possible autoimmune encephalitis were fulfilled. Our showed good response plasmapheresis therapy failure corticosteroid one. The Complications post-vaccination following SINOPHARM still seem be very rare, but should diagnosed treated appropriately.